Current Medicinal Chemistry
Title:Editorial (Thematic Issue: Synthesis, Evaluation and Pharmacological Applications of Antioxidants- Part 1)
Volume: 20 Issue: 36
Author(s): Fernanda Borges, Luciano Saso, Jorge Garrido and Sibel Suzen
Affiliation:
Export Options
About this article
Cite this article as:
Borges Fernanda, Saso Luciano, Garrido Jorge and Suzen Sibel, Editorial (Thematic Issue: Synthesis, Evaluation and Pharmacological Applications of Antioxidants- Part 1) , Current Medicinal Chemistry 2013; 20 (36) . https://dx.doi.org/10.2174/0929867311320360001
DOI https://dx.doi.org/10.2174/0929867311320360001 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Current Drug Targets Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Current Genomics Default Mode Network Connectivity and Related White Matter Disruption in Type 2 Diabetes Mellitus Patients Concurrent with Amnestic Mild Cognitive Impairment
Current Alzheimer Research The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary Tract
Current Diabetes Reviews Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Therapeutic Targets for Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Competitive Gly/NMDA Receptor Antagonists
Current Topics in Medicinal Chemistry New Vectors and Strategies for Cardiovascular Gene Therapy
Current Gene Therapy The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Hypertension in Diabetes: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Advances in Hydrogels Applied to Degenerative Diseases
Current Pharmaceutical Design Erythropoietin and Oxidative Stress
Current Neurovascular Research Mitochondrial Toxicity in HAART: An Overview of In Vitro Evidence
Current Pharmaceutical Design The Intestinal Absorption Mechanism of Gabapentin Makes it Appropriate for Gastroretentive Delivery
Current Clinical Pharmacology Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors
Current Neuropharmacology Molecular Genetics and Biomarkers of Polyglutamine Diseases
Current Molecular Medicine Poly-Pharmacy Among the Elderly: Analyzing the Co-Morbidity of Hypertension and Diabetes
Current Pharmaceutical Design A Role of GABA Analogues in the Treatment of Neurological Diseases
Current Medicinal Chemistry Antioxidant Therapy: Current Status and Future Prospects
Current Medicinal Chemistry Comprehensive Review On Oral Disintegrating Films
Current Drug Delivery